NTCOC
NEO icon

Northern Trust Company of Connecticut’s NeoGenomics NEO Stock Holding History

Northern Trust Company of Connecticut’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$157K Hold
43,339
– – ﹤0.01% 1823
2013
Q3 		$130K Hold
43,339
– – ﹤0.01% 1820
2013
Q2 		$172K Buy
+43,339
New +$165K ﹤0.01% 1731

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Company of Connecticut's NEO Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its NeoGenomics (NEO) position steady in Q4 2013 at 43,339 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Northern Trust Company of Connecticut first reported a position in NEO in Q2 2013 and has held it in 3 quarters since. The position peaked at $172K in Q2 2013. 64 funds tracked by Wall St. Rank hold NEO as of Q4 2013.

  • Northern Trust Company of Connecticut held 43,339 shares of NeoGenomics worth $157K as of Q4 2013.
  • Northern Trust Company of Connecticut left its NeoGenomics share count unchanged in Q4 2013.
  • NeoGenomics made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1823 holding.
  • Northern Trust Company of Connecticut first reported a position in NeoGenomics in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's NeoGenomics position peaked at $172K in Q2 2013.
  • 64 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.